The large subunits of herpes simplex virus types 1 and 2 ribonucleotide reductases contain unique aminoterminal regions comprising 311 and 318 residues respectively, which are not found in ribonucleotide reductases from other sources. We report the mapping of the epitope recognized by monoclonal antibody 1026, which is specific for the large subunit (R1) of HSV-1, and then deduce the structural relationship of the amino-terminal region of R1 with the rest of the protein.
Introduction
Ribonucleotide rednctase (RR) (EC 1.17.4.1) catalyses the formation of deoxyribonucleotides by reduction of the four corresponding ribonucleoside diphosphates (Thelander & Reichard, 1979) . The enzyme is essential for DNA synthesis (Reichard, 1988) . A novel RR activity is encoded by several herpesviruses including herpes simplex virus (HSV) (Averett et al., 1983; Dutia, 1983; Preston et al., 1984; Huszar & Bachetti, 1981; Swain & Galloway, 1986; McGeoch et al., 1988) , Epstein-Barr virus (EBV) (Henry et al., 1978; Baer et al., 1984; Gibson et al., 1984) , varicella-zoster virus (VZV) (Davison & Scott, 1986; Spector et al., 1987) , and equine herpesvirus type 1 (EHV-1) (Cohen et al., 1987; Telford et al., 1992) . In addition, pseudorabies virus induces a novel activity (Lankinen et al., 1982; Cohen et al., 1987) . HSV RR is composed of two non-identical proteins forming an 0~2/~ 2 type of structure, where ~ represents the large subunit (R1) and fl the small snbunit (R2) (Frame et al., 1985; Bacchetti et al., 1986; Darling et al., 1988; Ingemarson & Lankinen, 1987) .
In mice, the HSV RR enzyme is essential for virulence, ] Present address : Department of Virology, University of Helsinki, Haartmaninkatu 3, 00290 Helsinki, Finland. growth in the eye and trigeminal ganglia and reactivation from latency (Cameron et al., 1988; Jacobsen et al., 1989) . It is also required for efficient growth in primary human corneal fibroblasts (Brandt et al., 1991) . These observations, together with the discovery that a peptide corresponding to the carboxy terminus of R2 specifically inhibits the enzyme (Dutia et al., 1986; Cohen et al., 1986) by interfering with the normal association between the R1 and R2 subunits (McClements et al., 1988; Paradis et al., 1988; Darling et al., 1990) , have stimulated interest in the enzyme as a possible antiviral target.
Amino acid sequence analysis indicates distinct homologies between HSV RR and the RRs encoded by EBV, VZV, EHV-1, vaccinia virus, Escherichia coli, bacteriophage T4 and mouse (Eriksson & SjSberg, 1989; Telford et al., 1992) . However, a striking feature of R1 from HSV-1 and HSV-2 is the presence of an additional amino-terminal region of 311 and 318 amino acids, respectively (Nikas et al., 1986) . For HSV-1 at least, this N-terminal extension is unnecessary for ribonucleotide reduction (Lankinen et al., t989; Conner et al., 1992b) .
Unlike the gene encoding HSV-2 R2, which is expressed with typical early kinetics, that encoding R1 is transcribed (at low levels) during a cycloheximide block and therefore has some of the characteristics of an immediate early gene (Clements et al., 1977; Preston et at., 1978; Watson etal., 1979; Sze &Herman, 1992 (Nikas et al., 1986) .
? Numbering is from the initiation ATG codon of the R1 coding region. $ The F2 fusion protein was expressed from a construct that carried a tandem insertion of two NruI-ScaI fragments in the correct orientation.
§ Filled at the 3' end.
N-terminal domain of HSV R1 has been proposed to have a function distinct from ribonucleotide reductase activity (Conner et al., 1992 a) . The N-terminal domains of both HSV-1 and HSV-2 R1 have been shown to possess a protein kinase activity (Ali et al., 1991 ; Chung et al., 1989 Chung et al., , 1990 Conner et al., 1992a; Luo et al., 1991 ; Luo & Aurelian, 1992; Paradis et al., 1991) . However, Conner et al. (1992a) were able to demonstrate only a single autophosphorylation in homogeneous preparations of HSV-1 R1, which suggests that the HSV-1 R1 protein kinase has a restricted substrate specificity. It has been proposed that the kinase activity of the unique N terminus of HSV-2 R1 (Chung et al., 1990; Ali et al., 1991 ; Luo & Aurelian, 1992 ) is related to the ability of a restriction fragment from the HSV-2 genome that encodes this region of the protein to transform cells (Jariwalla et al., 1980; Hayashi et al., 1985; . Our long term goal is to understand the structure of HSV-1 R1. Proteins containing fl-galactosidase fused to fragments of R1 have been produced. We describe mapping of the epitope recognized by an Rl-specific monoclonal antibody (MAb), 1026 (Nikas et al., 1990) , using the R1 fragment/fl-galactosidase fusion proteins. Fine mapping of the epitope with synthetic peptides revealed that the unique N-terminal region forms a discrete domain which is linked to the conserved carboxy region by an exposed loop. The functional relevance of this arrangement is discussed.
Methods

HSV-1 R1 and R2 proteins and amino-terminal truncations of R1.
The R1 and R2 proteins were overexpressed in E. coli BL21 DE3 cells and purified from the bacterial extracts as described Lankinen et al., 1991) . Amino-terminal truncations dN305R1 and dN246R1 were created by trypsin and chymotrypsin cleavage of R1 (Conner et al., 1992b) .
Expression of fragments of R1 as fusion proteins.
The cloning strategy used to generate the fusion proteins is shown in Table 1 . The R1 gene was cleaved to give 10 different fragments using restriction sites that were available. Each fragment was fused to the 3' end of the flgalactosidase gene by cloning it into the appropriate pEX expression vector so as to maintain the correct reading frame at the site of fusion (Stanley & Luzio, 1984) . The predicted reading frame sequence of the recombinant clones was confirmed by sequencing across the 3' to 5' fusion site using a T7 sequencing kit (Pharmacia) and an oligonucleotide (GGTGGCGACTCCTGG) which primes just before the 3 ~ end of the fl-galactosidase gene. The recombinant plasmids were transformed into E. coli strain K12AHIAtrp cells which carry the defective ,t prophage 2Nam7Nam53cI857AH1 (Stanley & Luzio, 1984) and were propagated at 31 °C under ampicillin selection. Expression of the fusion proteins was induced by raising the temperature to 42 °C, thus inactivating the repressor and allowing transcription from the phage 2 PR promoter which drives the fl-galactosidase gene in the pEX vector system. Antisera. MAb 1026 specific for R1 has been described (Nikas et al., 1990) . Antipeptide antiserum C2 was raised against a peptide corresponding to residues 959 to 970 of HSV R1 (Lankinen et al., 1989) .
SDS-PAGE and Western blotting.
Proteins were solubilized by boiling in sample buffer (0.05M-Tris-HC1 pH 6.8, 2% SDS, 5% mercaptoethanol and 10% glycerol) and separated by SDS-PAGE using 7-5 % gels (Laemmli, 1970) . Western blots (Towbin et al., 1979) were performed as described earlier using antiserum C2 and MAb 1026 at dilutions of 1:50 and 1:200 respectively (Lankinen et al., 1989) .
Synthetic peptides. Peptides were synthesized by continuous flow F-moc chemistry (reviewed by Atherton et aL, 1979; Sheppard, 1983) . The M r values of peptides were determined by mass spectrometry (M-Scan) which gave values identical to those expected. according to the manufacturer's instructions to produce an antibody affinity matrix. Partially purified RI from an ammonium sulphatefractionated extract of E. coli was bound to the matrix by mixing equal volumes of extract and matrix in Eppendorf tubes for 1 h at room temperature. To remove unbound R1 the matrix was then washed with 25 mM-HEPES pH 7.6 containing 2 mM-DTT and 0.5 M-NaC1, twice more with the same buffer containing 2 M-NaC1 and finally once with 0"1 M-glycine-HC1 pH 2.5. To test the ability of peptides to dissociate R1 from MAb 1026, equal volumes of matrix and a 1 mM solution of the peptide were briefly mixed at room temperature and the matrix was pelleted by centrifugation. Proteins in the supernatant and matrix samples were analysed by SDS-PAGE and visualized by staining with Coomassie blue.
Peptide-induced dissociation of R1 from
Results
R1 fragment/fl-galactosidase fusion proteins
Ten E. coli clones expressing fragments of HSV-1 R1 spanning the entire protein and fused to fl-galactosidase were p r e p a r e d as described above. The fusion proteins were expressed at 37 °C after incubating the cultures at 42 °C for 15 min. 
Epitope mapping of MAb 1026
M A b 1026 was tested for reactivity with the 10 fusion proteins by Western blotting (Fig. 2 a) . It reacted with F2 and F3 (lanes 4 and 5) but not with any of the other fusion proteins (lanes 3 and 6 to 12) nor with /qgalactosidase (Fpex, lane 2). As expected it reacted with intact R1 (lane 1) which adventitiously has the same mobility as F2. These reactivities are summarized in Fig. 1 , (b) Intact R1 (lanes 1 and 4) and proteolytic fragments dN246R1 (lanes 2 and 5) and dN305R1 (lanes 3 and 6) probed with antiserum C2 (lanes 1, 2 and 3) and MAb 1026 (lanes 4, 5 and 6).
respectively of R 1 (Conner et al., 1992 b) . Preparations of intact R1, dN246R1 and dN305R1 were separated by SDS-PAGE, transferred to a nitrocellulose membrane and probed with either antiserum C2 (Fig. 2 b, lanes 1 to  3) to identify the positions of the three proteins or MAb 1026 (Fig. 2b , lanes 4 to 6). As observed previously (Lankinen et al., 1989) of R1 (lane 1). dN246R1 appears largely homogeneous (lane 2) whereas dN305R1 contains in addition both larger and smaller proteolytic fragments (lane 3). MAb 1026 bound to intact R1 (lane 4) and dN246R1 (lane 5) but not dN305R1 (lane 6). These reactivities are summarized in Fig. 3 and suggest that at least part of the epitope recognized by MAb 1026 lies between residues 282 and 305. To fine map the epitope recognized by MAb 1026, six overlapping peptides, P1 to P6, spanning residues 282 to 327 (Fig. 3) were synthesized and tested for their ability to elute R1 from MAb 1026 affinity matrix. The experiment was performed both by Western blots probed with antiserum C2 (Fig. 4a) and by visualizing total protein by staining with Coomassie blue (Fig. 4b) . Fig.  4(a) shows that peptides P5 (lane 11) and P2 (lane 13) displaced R1 from the MAb 1026 whereas peptides P6, P3, P4 and P1 (lanes 8, 9, 10 and 12) did not. Fig. 4(b) (in which duplicate samples were run in adjacent lanes) shows that from total protein (lanes 1 and 2) applied to the MAb 1026 matrix after washing (lanes 5 to 8) essentially only R1 was bound (lanes 9 and 10). The two products of lower M r in lanes 9 and 10 are probably truncations of R1. R1 was dissociated from the Mab 1026 matrix with peptide P2 (lanes 11 and 12) and peptide P5 (lanes 13 and 14) but not any other peptide (data not shown). Peptides P2 and P5 correspond to the residues 289 to 303 and 308 to 323 respectively, which are adjacent but not contiguous (Fig. 3) . This finding suggests that the epitope recognized by MAb 1026 is discontinuous. 2) and R1 remaining in the supernatant after incubation with the MAb 1026 matrix and centrifugation to pellet the matrix (lanes 3 and 4). Proteins eluted by the low salt wash are shown in lanes 5 and 6 and those eluted by the high salt wash are shown in lanes 7 and 8. Samples of MAb 1026 matrix-bound R1 (50 gl; lanes 9 and 10) were incubated with peptides. R 1 released by peptide P5 is shown in lanes 11 and 12, and by P2 in lanes 13 and 14.
Discussion
In this communication we have examined the structural linkage between the unique amino-and conserved carboxy-terminal regions of HSV-1 R1 and suggest that it is in the form of an exposed loop. Our model is based in part on the mapping data of the epitope recognized by MAb 1026. The epitope is formed by two sites defined by peptides P2 and P5, corresponding to residues 289 to 303 and 308 to 323 (Fig. 3) . The two antibody recognition sites were identified by the ability of peptides P2 and P5 to displace R1 from MAb 1026. Direct evidence for the interaction of P2 with the antibody was obtained from the observation that a branched form (Tam, 1988) of P2 was selectively retained on a MAb 1026 column: the retained peptide was visualized by SDS-PAGE and staining with Coomassie blue (data not shown). The two recognition sites are likely to be separate since peptides P2 and P5 do not overlap whereas peptides P3 and P4, both of which overlap the junction between P2 and P5, were unable to displace R1.
These data suggest that regions of R1 equivalent to those in P2 and P5 fold to form a loop structure to which the MAb binds. This loop conformation can be regained after denaturation since 1026 recognizes R1 in Western blots. However, it is destroyed by trypsin cleavage and the trypsin-sensitive site has been mapped to an arginine residue at position 305 (Conner et al., 1992b) , midway between the P2 and P5 peptide recognition sites. It has been shown that R 1 truncated with trypsin at residue 305 still retains full catalytic activity (Conner et al., 1992b) . The 30K N-terminal fragment generated this way retains protein kinase activity (Conner et al., 1992a) . Thus the junction between the two domains is probably an exposed structure. Its sensitivity to cleavage by trypsin contrasts with the relative resistance of the conserved carboxy region of R1 (Conner et al., 1992b; Lankinen et al., 1989) .
The existence of the exposed loop may be important in the replication of the virus. We have previously demonstrated cleavage within the loop in HSV-l-infected BHK cells and have demonstrated that the resulting carboxydomain accumulated exclusively within the nucleus or in material tightly adhering to the nucleus (Lankinen et al., 1989) . Such a location is different from the cytoplasmic location of cellular RR, but still compatible with a role in ribonucleotide reduction. In contrast, the aminoterminal domain of HSV-2 R1 associates with cellular membranes (Chung et al., 1989; Luo & Aurelian, 1992) and this localization does not suggest a role in ribonucleotide reduction. We therefore propose that the proteolytically sensitive loop between the N-and Cterminal domains of R1 allows for cleavage and the separate localization of these regions of the protein. The existence of a similarly trypsin-sensitive site in HSV-2 R1 has not been demonstrated although it is interesting to note that a 29K fragment from the N terminus of HSV-2 R1 is also active in protein kinase assays (Luo et al., 1991) .
The precise function of the amino-terminal domains of HSV R1 remains unknown and further investigation is required. For elucidation of the mechanisms for R1 translocation and compartmentalization it will be important to determine whether the HSV-1 amino terminus is also located in the cellular membranes. Moreover, because HSV becomes latent in neurons it will also be important to determine the distribution of intact R1 and its cleavage products or truncated forms in neuronal cells.
